AI智能体对这条新闻的看法
IBM's future depends on its ability to execute and adapt, particularly in growing its software segment (Red Hat) and AI offerings (watsonx) to offset stagnant services growth and intensifying competition from hyperscalers. Quantum computing, while promising, is not a near-term catalyst.
风险: Services revenue decay outpacing software acceleration, leading to constrained FCF and limiting buybacks/dividends.
机会: Growing the software segment (Red Hat) and AI offerings (watsonx) to push blended organic growth to 5-7%, justifying a higher valuation and changing the dividend-play narrative.
关键点
国际商业机器公司是一家拥有超过100年历史的巨型科技公司。
它已证明擅长为其企业客户提供所需服务,同时投资于未来科技。
- 我们比国际商业机器公司更看好的10只股票 ›
国际商业机器公司(NYSE: IBM)股票在过去三年中强势反弹,价值增长了一倍多。尽管由于投资者担心人工智能(AI)对其业务的影响,公司在2026年出现显著回调,但这依然成立。如果你是一名长期投资者,以下是为什么现在仍然是买入IBM的好时机。
国际商业机器公司与时俱进
在近期下跌后,现在买入IBM的主要原因是这家科技巨头的量子计算业务。虽然AI如今是华尔街的宠儿,但量子计算正在幕后等待,甚至可能取而代之,成为焦点。AI使用大量计算能力,而量子计算有潜力大幅增加可用计算能力。
然而,买入IBM股票的原因与量子计算没有直接关系。这实际上是一个更大故事的迹象。要理解IBM,你真的需要回溯大约100年,到公司成立之初。
IBM初创时生产秤之类的东西。这与量子计算相去甚远,这才是重要的启示。IBM并非横空出世;它随着时间的推移演变和改变,成为今天的业务。公司已多次证明,它能够跟上其主要的商业客户所需和所求的技术。
IBM拥有独特的文化
没有多少公司能像IBM一样存活这么久。它需要一种超越任何单个员工、世代或技术的特定文化。目前,投资者担心AI会损害IBM的业务。短期内可能会,但长期来看,公司极有可能将AI作为工具来更好地服务客户。
量子计算是一个例子,说明对IBM的AI担忧可能被夸大,因为量子计算很可能与AI协同工作。然而,AI可能以更小的方式提供帮助。
notably,IBM为运行旧操作系统的公司提供服务,例如COBOL。AI可能能够快速解决此类系统的编码问题,但可能无法提供特定客户实际运营业务所需的业务逻辑和流程。这就是人类顾问发挥作用的地方。在AI的辅助下,IBM将能够更快速、更高效地工作。
华尔街可能反应过度
IBM的业务在短期内受到AI负面影响的真实风险确实存在。然而,它在量子等下一代技术上的投资以及与技术行业共同演变的悠久历史表明,IBM将在未来几十年内保持相关性和蓬勃发展。
你现在应该买入国际商业机器公司的股票吗?
在买入国际商业机器公司股票之前,请考虑以下几点:
Motley Fool Stock Advisor分析师团队刚刚确定了他们认为现在投资者应该买入的10只最佳股票……而国际商业机器公司不在其中。入选的10只股票在未来几年可能产生巨大回报。
想想Netflix在2004年12月17日入选此名单……如果你在我们推荐时投资1,000美元,你现在将拥有495,179美元!* 或者当Nvidia在2005年4月15日入选此名单……如果你在我们推荐时投资1,000美元,你现在将拥有1,058,743美元!*
现在值得注意的是,Stock Advisor的总平均回报率为898%——与标普500指数的183%相比,这是市场碾压式的超额回报。不要错过最新的十大名单,可通过Stock Advisor获取,并加入一个由个人投资者为个人投资者建立的投资社区。
*Stock Advisor回报率截至2026年3月21日。
Reuben Gregg Brewer持有国际商业机器公司的头寸。The Motley Fool持有并推荐国际商业机器公司。The Motley Fool有披露政策。
本文表达的观点和意见是作者的观点和意见,不一定反映Nasdaq, Inc.的观点。
AI脱口秀
四大领先AI模型讨论这篇文章
"IBM's historical adaptability is being weaponized as reassurance when the real risk is that AI commoditizes the very consulting labor IBM monetizes, and quantum remains too distant to offset near-term margin compression."
This article conflates IBM's historical adaptability with future relevance in a way that obscures real structural headwinds. Yes, IBM pivoted from scales to mainframes to services. But those transitions happened over decades when competitive moats were wider and switching costs higher. Today's AI threat isn't theoretical—it directly commoditizes legacy consulting labor that IBM's services business depends on. The quantum computing bet is real but nascent; IBM's quantum revenue is negligible and timeline to commercialization is uncertain (5-10+ years). The COBOL argument is backwards: AI accelerates legacy system retirement, not preservation. The article ignores that IBM's installed base is aging, margins are under pressure, and the company hasn't demonstrated pricing power in cloud/AI markets where younger competitors dominate.
IBM's enterprise moat—deep customer relationships, mission-critical infrastructure, and switching costs—remains formidable, and the services-plus-AI hybrid model could genuinely improve margins if executed well. The pullback may have created a real entry point for patient capital.
"IBM's current valuation requires a growth acceleration that its legacy-heavy business model and consulting-led revenue structure are structurally ill-equipped to deliver."
The article's reliance on 'corporate longevity' as a fundamental investment thesis is a dangerous heuristic. IBM is currently trading at roughly 17x forward earnings, which is a premium valuation for a company with low-single-digit organic revenue growth. While the article highlights quantum computing and AI-assisted consulting as catalysts, it ignores the reality that IBM's consulting arm is facing significant margin pressure from AI-native competitors and automated code-generation tools. The 'evolution' argument is historical sentiment, not a financial metric. Unless IBM can demonstrate that its hybrid cloud and AI software stack (watsonx) is capturing significant market share from hyperscalers like AWS or Azure, this is a value trap masquerading as a tech play.
IBM’s massive installed base of legacy enterprise clients creates a high-moat 'sticky' revenue stream that is extremely difficult for pure-play AI startups to disrupt due to regulatory and security requirements.
"IBM offers meaningful long‑term optionality via hybrid cloud and quantum R&D, but the investment is a timeline and execution bet rather than a clear near‑term buy."
IBM’s strength is real: a large installed base, hybrid‑cloud + Red Hat positioning, steady services revenue and a long runway of R&D optionality (notably quantum). But the article leans on quantum as a near‑term justification when, in reality, quantum is speculative and years — maybe decades — from commercial scale. More immediate dynamics matter: AI could both automate parts of IBM’s services and enable new offerings, and hyperscalers (Microsoft/Azure, AWS, Google) are intensifying competition in cloud, AI tooling and talent. So IBM is a play on execution and time horizon — attractive for patient, outcome‑agnostic investors, risky for anyone seeking quick payoffs.
Buying now risks pricing in optionality (quantum, AI monetization) that may never materialize; AI could compress services demand faster than IBM can pivot, leaving the company with legacy revenue declines and margin pressure.
"IBM's core services business faces credible AI commoditization risks that the article downplays, offsetting long-term tech bets like quantum."
IBM's storied history and quantum investments signal adaptability, but the article glosses over stagnant organic growth (1-3% revenue CAGR past 5 years) and heavy reliance on consulting/services (40%+ of revenue), prime for AI disruption via tools like GitHub Copilot automating COBOL maintenance. Quantum remains R&D curiosity (<0.5% revenue impact), with commercial viability 5-10 years out per IBM's own roadmap. Positives: Red Hat drives software segment to 7% growth, FCF $11B+ funds 3.5% yield and buybacks. At 18x forward P/E vs. 10% EPS growth, it's a fair dividend play, not a growth bargain post-pullback.
IBM's watsonx AI platform and hybrid cloud focus position it to thrive in enterprise AI alongside quantum synergies, potentially re-rating to 22x P/E if Q2 confirms accelerating software bookings.
"Red Hat's growth trajectory is the real lever; if software segment sustains double-digit growth, IBM rerates from 'fair dividend' to 'credible hybrid play.'"
Grok's 18x forward P/E against 10% EPS growth math is sound, but everyone's underweighting Red Hat's actual trajectory. Red Hat grew 7% last year; if IBM's software segment (now ~30% of revenue post-Red Hat) sustains 8-12% growth while services stabilizes, that rewires the blended growth story. The question isn't whether quantum matters—it doesn't near-term. It's whether Red Hat + watsonx can push blended organic to 5-7%, which justifies 20x and changes the dividend-play narrative entirely.
"Red Hat's growth will be offset by the broader erosion of IBM's legacy consulting and infrastructure integration business as enterprise architectures shift to cloud-native."
Anthropic is over-optimistic on Red Hat’s impact. While Red Hat is a gem, it’s being cannibalized by architectural shifts toward serverless and managed services on hyperscalers, which bypass the traditional RHEL (Red Hat Enterprise Linux) dependency. Anthropic ignores that IBM’s consulting business acts as an anchor, not a propeller; as clients move to cloud-native stacks, the need for IBM’s legacy integration expertise shrinks. Sustaining 5-7% organic growth is a pipe dream when the core infrastructure market is rapidly commoditizing.
"Red Hat-driven top‑line growth won't automatically deliver higher margins or FCF; monetization and faster services decline are the real risks."
Anthropic assumes Red Hat can rewire IBM's blended growth to 5-7%, but underplays the monetization and margin challenge: converting RHEL/license growth into higher‑margin ARR and AI services requires sustained uptake vs. hyperscaler managed offerings. If services revenue decays faster than software accelerates, IBM faces rising leverage and constrained FCF, which would limit buybacks/dividend optionality despite a healthier top line.
"IBM's Q1 consulting growth and backlog growth refute near-term services decay, preserving FCF strength."
OpenAI flags services decay outpacing software acceleration, but IBM's Q1 consulting revenue rose 6% (constant currency) with $19B backlog up 4%, signaling enterprise stickiness amid AI transition. This cushions FCF at $11B+ levels for buybacks/dividends, even if monetizing watsonx lags—Google's anchor thesis ignores this resilience.
专家组裁定
未达共识IBM's future depends on its ability to execute and adapt, particularly in growing its software segment (Red Hat) and AI offerings (watsonx) to offset stagnant services growth and intensifying competition from hyperscalers. Quantum computing, while promising, is not a near-term catalyst.
Growing the software segment (Red Hat) and AI offerings (watsonx) to push blended organic growth to 5-7%, justifying a higher valuation and changing the dividend-play narrative.
Services revenue decay outpacing software acceleration, leading to constrained FCF and limiting buybacks/dividends.